Latus Pharma ApS: Financial statements 2018
CVR: 36974214
Source: annual report 2018, Danish Business Authority
01/01/2018 – 31/12/2018
Latus Pharma ApS (CVR 36974214) has filed annual accounts for 2018. In 2018, the company reported a gross profit of DKK -4,352 and a net result of DKK -4,352 compared with DKK -64,823 the year before. Equity in the 2018 report amounted to DKK 130,965. The solvency ratio was 100%.
- Revenue
- DKK 0
- Gross Profit
- DKK -4,352
- Profit/Loss
- DKK -4,352
- Equity
- DKK 130,965
- Total Assets
- DKK 130,965
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2018 | 0 | -4 t. | -4 t. | 131 t. | - |
| 2017 | 11 t. | -65 t. | -65 t. | 135 t. | - |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2018
Latus Pharma ApS has published its annual report for 2017. Revenue came to DKK 10,800, and the net result was DKK -64,823.
About Latus Pharma ApS
Latus Pharma ApS is a Danish company of the type Anpartsselskab based in Køge, founded in 2015. The company is registered under the industry Andre liberale, videnskabelige og tekniske tjenesteydelser i.a.n.. The management consists of Jørgen Wittendorff. The company is owned by Jørgen Wittendorff. In 2025, the company reported revenue of DKK -6,991 and a net result of DKK -6,991 compared with DKK -6,897 the year before. Equity in the 2025 report amounted to DKK 82,569.